Stocks making the biggest moves after the bell: H&R Block, Cava, Stride and more

Market Insider

The New York Stock Exchange welcomes executives and guests of Cava in celebration of its initial public offering, June 15, 2023.
NYSE

Check out the companies making headlines in extended trading.

H&R Block — The tax preparer rose nearly 5.9% after posting quarterly earnings per share of $2.05 that beat Wall Street’s expectations of $1.88, according to Refinitiv. H&R Block reported $1.03 billion in revenue, while analysts expected $1.01 billion. The company also increased its quarterly dividend 10.3% to $0.32 from $0.29 and raised its full-year guidance.

Cava — Shares of the Mediterranean restaurant chain advanced 4.3% after hours following a second-quarter earnings report that topped consensus estimates. The fast-casual chain posted $172.9 million in revenue, exceeding analysts’ expectations of $163.2 million, according to FactSet. Earnings per share came to $0.21, while analysts surveyed by FactSet had forecast a loss of $0.02.

AgEagle Aerial Systems — Shares climbed 3% after the bell following the company reporting a smaller loss per share in the second quarter than it did in the same quarter a year ago. AgEagle reported a loss of 5 cents per share, 2 cents less than in 2022. But the company reported a smaller quarterly revenue than a year ago at $3.3 million.

Mercury Systems — The defense stock dropped 10.4% after missing Wall Street expectations for the fiscal fourth quarter. Mercury reported profit of 11 cents per share, excluding items, on revenue of $263.2 million. Analysts surveyed by FactSet estimated 52 cents earned per share and revenue of $278.8 million for the quarter. The company’s full-year guidance similarly missed FactSet consensus forecasts.

Stride — Shares popped 8.9% after the educational technology stock delivered a better-than-expected report in its fiscal fourth quarter. GAAP earnings per share of $1.01 topped the consensus estimate from analysts polled by FactSet by 14 cents, while revenue of $483.5 million also exceeded the forecast $460.7 million.

Articles You May Like

Hedge funds performed better under Democratic presidents than Republican ones, history shows
Caligan picks up a stake in Verona Pharma, seeing an opportunity to generate more value
The Three Catalysts Sending Stocks to the Moon
5 Stocks to Buy on a Trump Victory 
AI’s Dark Horse Could Become Its Crown Jewel Under Trump